About Medical Engineering Technologies UK
Expert Physical, Packaging and Analytical Chemistry Testing in the UK
MET is an ISO/IEC 17025-accredited Cormica laboratory based in Dover, UK. They specialise in physical, functional, packaging, and analytical chemistry testing, with world-leading expertise in extractables & leachables studies and combination device testing.
Since 1997, they have combined decades of knowledge with cutting-edge technology to help medical device and pharmaceutical manufacturers bring safe, effective products to market. their risk-based approach supports product validation, materials characterisation, and performance testing with precision and reliability.
Their services include packaging validation, functional performance testing, chemical testing including comprehensive extractables & leachables analysis, all delivered to internationally recognised standards. In addition, their Consultancy department provides expert support with Biological Evaluation Plans/Reports (BEP/BER) and Clinical Evaluation Plans/Reports (CEP/CER), guiding clients through complex regulatory requirements with clarity and confidence.
Clients worldwide choose MET for our unwavering commitment to quality, compliance, and patient safety.
Device Verification and Validation
- Luer Lock Dimensional Testing
- Break Loose / Glide Force Testing
- Needle Cap Removal Force Testing
- Injection Force Testing
- Catheter Performance Testing
- Infusion Set Testing
- Dose Accuracy Testing
- Wound Dressing Performance Testing
Specific Device Testing:
Transit / Packaging Validation & Verification
- Transit & Distribution Simulation
- Real-time / Accelerated Ageing & Stability Testing
- Packaging Validation & Verification
- Bubble Leak Test (Internal Pressurisation)
- Peel Strength Testing
- Dye Penetration Testing
- Burst Testing
- Container Closure Integrity Testing (CCIT)
- Vacuum Decay
- Blue Dye Immersion
- Hydrogen Leak Detection
- Microbial Ingress
Analytical Chemistry
• Extractables and Leachables
• Volatile organic compounds (VOC & VOS) / Leachables in Condensate
• Residual testing (assessment of processing residuals (BPOG)
• Degradation studies
Regulatory Consultancy
- ISO 10993 Biocompatibility TestingÂ
- Biological Evaluation Plans (BEP)
- Biological Evaluation Reports (BER)
- Clinical Evaluation Plans (CEP) & Reports (CER)
- US FDA Submission Support
- UK & EU MDR Submission SupportÂ
- Toxicological Risk Analysis
- Biological Gap Analysis
- Post-Market Surveillance (including PSUR)
MET's Team & Expertise
We help medical device companies worldwide bring life-saving products to market with confidence. From early development to market release, our expert’s partner with engineers and manufacturers to deliver trusted results. Our commitment to quality and regulatory compliance is at the heart of what we do.
Our people are the core to MET’s success with expertise and experience spanning transit simulation, physical performance testing, analytical chemistry, and regulatory consultancy.
What sets us apart is our adaptability, whether you need a standard protocol or a fully bespoke test plan, our flexible and robust programmes are designed by our experts to support your product’s success.
Angela Bell
MET General Manager
Steven Malbon
Combination & Physical Devices Manager
Luminita Moraru
Analytical Chemistry Manager
Elena Henderson
Principal Consultant
Michelle Latter
Quality Assurance Manager
Baden Bowen
Transit Packaging Manager
Inside Medical Engineering Technologies Laboratory
Medical engineering Technologies History
Medical Engineering Technologies Ltd (MET) was founded in 1996, originally under the name Campus Medical, before adopting its current name in 1997.
Established by Mark Turner, a cardiopulmonary bypass machine technician and R&D engineer, the company was built on a clear vision: to create a laboratory that could deliver comprehensive, high-quality testing plans across multiple disciplines, ensuring medical devices reached patients with proven performance and safety.
From the very beginning, MET has focused on continual improvement and expanding capabilities. Key milestones include achieving ISO 9001 accreditation in 1999, UKAS ISO 17025 accreditation in 2012, relocating to larger premises in Dover in 2013, and introducing extractables and leachables testing in 2017 and combination device testing in 2018. Along the way, services have broadened to include sterile packaging validation, transit simulation testing, dressing performance testing, analytical chemistry, and specialist regulatory consultancy.
In 2022, MET joined the Cormica Group under Limerston Capital, strengthening its position as a trusted global partner. Today, MET combines decades of expertise with state-of-the-art facilities to deliver robust, reliable, and flexible testing solutions. Our commitment to quality and patient safety remains at the core of everything we do, helping clients worldwide bring safe, effective medical devices to market with confidence.
Cormica's Global Locations
Trusted Testing Partner Across the Globe
With facilities in the US, UK, and EU, Cormica provides expert testing solutions to support medical device and pharmaceutical manufacturers worldwide.
